نتائج البحث - "Royer PJ"

المؤلفون: Viklicky O; Department of Nephrology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic., Slatinska J; Department of Nephrology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic., Janousek L; Department of Nephrology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic., Rousse J; Xenothera, Nantes, France., Royer PJ; Xenothera, Nantes, France., Toutain PL; Comparative Biomedical Sciences, The Royal Veterinary College, London, United Kingdom.; INTHERES, Université de Toulouse, INRAE, ENVT, Toulouse, France., Cozzi E; Transplantation Immunology Unit, Padua University Hospital, Padova, Italy., Galli C; Avantea, Laboratory of Reproductive Technologies, Cremona, Italy., Evanno G; Xenothera, Nantes, France., Duvaux O; Xenothera, Nantes, France., Bach JM; Oniris, INRAE, IECM, USC 1383, Nantes, France., Soulillou JP; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.; Nantes Université, INSERM UMR1064, Center for Research in Transplantation and Translational Immunology, Nantes, France., Giral M; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.; Nantes Université, INSERM UMR1064, Center for Research in Transplantation and Translational Immunology, Nantes, France., Vanhove B; Xenothera, Nantes, France., Blancho G; Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.; Nantes Université, INSERM UMR1064, Center for Research in Transplantation and Translational Immunology, Nantes, France.

المصدر: Transplantation [Transplantation] 2024 Jul 01; Vol. 108 (7), pp. e139-e147. Date of Electronic Publication: 2024 Feb 29.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6080 (Electronic) Linking ISSN: 00411337 NLM ISO Abbreviation: Transplantation Subsets: MEDLINE

View record in Lippincott, Williams & Wilkins

Full Text Finder

7

دورية أكاديمية

Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19.

المؤلفون: Poulakou G; 3rd Department of Internal Medicine, Medical School, Sotiria General Hospital, National and Kapodistrian University of Athens, Athens, Greece., Royer PJ; Xenothera, Nantes, France., Evgeniev N; Department of Medical Oncology, Complex Oncology Center, Russe, Bulgaria., Evanno G; Xenothera, Nantes, France., Shneiker F; Xenothera, Nantes, France., Marcelin AG; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France., Vanhove B; Xenothera, Nantes, France., Duvaux O; Xenothera, Nantes, France., Marot S; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France., Calvez V; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France.

المصدر: Frontiers in immunology [Front Immunol] 2024 Apr 17; Vol. 15, pp. 1330178. Date of Electronic Publication: 2024 Apr 17 (Print Publication: 2024).

نوع المنشور: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Multicenter Study; Clinical Trial, Phase III

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: SARS-CoV-2*/immunology , COVID-19*/immunology , COVID-19*/therapy , Antibodies, Viral*/immunology , Antibodies, Viral*/therapeutic use , COVID-19 Drug Treatment* , Antibodies, Neutralizing*/immunology , Antibodies, Neutralizing*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Double-Blind Method ; Aged ; Adult ; Treatment Outcome ; Severity of Illness Index

Full Text Finder

8

دورية أكاديمية

Polyclonal antibodies selectively inhibit tumor growth and invasion and synergize with immune checkpoint inhibitors.

المؤلفون: Ciron C; Xenothera, Nantes, France., Morice P; Xenothera, Nantes, France., Rousse J; Xenothera, Nantes, France., Roy P; CRIP, Oniris, INRAE, Nantes, France., Royer PJ; Xenothera, Nantes, France., Gauthier O; CRIP, Oniris, INRAE, Nantes, France., Brouard S; Nantes Université, Inserm, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, Nantes, France., Duvaux O; Xenothera, Nantes, France., Bassissi F; Xenothera, Nantes, France., Vanhove B; Xenothera, Nantes, France.

المصدر: JCI insight [JCI Insight] 2024 Feb 08; Vol. 9 (3). Date of Electronic Publication: 2024 Feb 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE

مواضيع طبية MeSH: Immune Checkpoint Inhibitors* , Melanoma*/therapy, Humans ; Rabbits ; Animals ; Mice ; Swine ; Mice, Nude ; Immunization ; Cell Line, Tumor ; Antibodies, Neoplasm/pharmacology

Full Text Finder

9

Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants.

المؤلفون: Vanhove B; Xenothera, Nantes, France., Marot S; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France., So RT; Hong Kong University (HKU)-Pasteur Research Pole, School of Public Health, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China., Gaborit B; Department of Infectious Disease, Nantes University Hospital, Nantes, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) CIC1413, Nantes University Hospital, Nantes, France., Evanno G; Xenothera, Nantes, France., Malet I; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France., Lafrogne G; Xenothera, Nantes, France., Mevel E; Xenothera, Nantes, France., Ciron C; Xenothera, Nantes, France., Royer PJ; Xenothera, Nantes, France., Lheriteau E; Xenothera, Nantes, France., Raffi F; Department of Infectious Disease, Nantes University Hospital, Nantes, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) CIC1413, Nantes University Hospital, Nantes, France., Bruzzone R; Hong Kong University (HKU)-Pasteur Research Pole, School of Public Health, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Department of Cell Biology and Infection, Institut Pasteur, Paris, France., Mok CKP; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Duvaux O; Xenothera, Nantes, France., Marcelin AG; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France., Calvez V; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France.

المصدر: Frontiers in immunology [Front Immunol] 2023 Apr 28; Vol. 14, pp. 1208705. Date of Electronic Publication: 2023 Apr 28 (Print Publication: 2023).

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE; MEDLINE

10

دورية أكاديمية

Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.

المؤلفون: Pison C; Service Hospitalier Universitaire de Pneumologie Physiologie, Pôle Thorax et Vaisseaux, Fédération Grenoble Transplantation, CHU Grenoble Alpes, Grenoble, France.; Université Grenoble Alpes, INSERM 1055, Grenoble, France., Tissot A; Service de Pneumologie, Institut du Thorax, CHU Nantes, Nantes, France.; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, ITUN, Nantes, France., Bernasconi E; Unité de Transplantation Pulmonaire, Service de Pneumologie, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Suisse., Royer PJ; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, ITUN, Nantes, France., Roux A; Service de Pneumologie, Hôpital Foch, Suresnes, France.; Institut National de Recherche Pour l'Agriculture, l'Alimentation et l'Environnement, INRAE, Jouy-en-Josas, France., Koutsokera A; Unité de Transplantation Pulmonaire, Service de Pneumologie, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Suisse., Coiffard B; Service de Pneumologie et de Transplantation Pulmonaire, APHM, Hôpital Nord, Aix Marseille Univ, Marseille, France., Renaud-Picard B; Service de Pneumologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Inserm UMR 1260, Regenerative Nanomedicine, Université de Strasbourg, Strasbourg, France., Le Pavec J; Service de Chirurgie Thoracique, Vasculaire et Transplantation Cardiopulmonaire, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France., Mordant P; Service de Chirurgie Vasculaire, Thoracique et Transplantation Pulmonaire, Hôpital Bichat, AP-HP, INSERM U1152, Université Paris Cité, Paris, France., Demant X; Service de Pneumologie et Transplantation Pulmonaire, CHU de Bordeaux, Bordeaux, France., Villeneuve T; Service de Pneumologie, CHU de Toulouse, Université Toulouse III-Paul Sabatier, Toulouse, France., Mornex JF; Université de Lyon, Université Lyon 1, PSL, EPHE, INRAE, IVPC, Lyon, France.; Hospices Civils de Lyon, GHE, Service de Pneumologie, RESPIFIL, Orphalung, Inserm CIC, Lyon, France., Nemska S; UMR 7200 - Laboratoire d'Innovation Thérapeutique, Faculté de Pharmacie, CNRS-Université de Strasbourg, Illkirch, France., Frossard N; UMR 7200 - Laboratoire d'Innovation Thérapeutique, Faculté de Pharmacie, CNRS-Université de Strasbourg, Illkirch, France., Brugière O; Service de Pneumologie, Hôpital Foch, Suresnes, France.; Laboratoire d'Immunologie de la Transplantation, Hôpital Saint-Louis, CEA/DRF/Institut de Biologie François Jacob, Unité INSERM 1152, Université Paris Diderot, USPC, Paris, France., Siroux V; Team of Environmental Epidemiology Applied to the Development and Respiratory Health, Institute for Advanced Biosciences (IAB), Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France., Marsland BJ; Unité de Transplantation Pulmonaire, Service de Pneumologie, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Suisse.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia., Foureau A; Service de Pneumologie, Institut du Thorax, CHU Nantes, Nantes, France.; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, ITUN, Nantes, France., Botturi K; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, ITUN, Nantes, France., Durand E; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, ITUN, Nantes, France., Pellet J; European Institute for Systems Biology and Medicine, Vourles, France., Danger R; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, ITUN, Nantes, France., Auffray C; European Institute for Systems Biology and Medicine, Vourles, France., Brouard S; CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, ITUN, Nantes, France., Nicod L; Unité de Transplantation Pulmonaire, Service de Pneumologie, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Suisse., Magnan A; Service de Pneumologie, Hôpital Foch, Suresnes, France.; Institut National de Recherche Pour l'Agriculture, l'Alimentation et l'Environnement, INRAE, Jouy-en-Josas, France.

مؤلفون مشاركون: Members of the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction consortia

المصدر: Frontiers in medicine [Front Med (Lausanne)] 2023 Mar 09; Vol. 10, pp. 1126697. Date of Electronic Publication: 2023 Mar 09 (Print Publication: 2023).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

Full Text Finder

تنقيح النتائج